Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,173
Closed -$90K 141
2021
Q4
$90K Sell
1,173
-396
-25% -$31.5K 0.11% 102
2021
Q3
$118K Buy
1,569
+412
+36% +$31.3K 0.19% 19
2021
Q2
$90K Buy
1,157
+102
+10% +$7.59K 0.18% 33
2021
Q1
$78K Sell
1,055
-470
-31% -$34.7K 0.18% 50
2020
Q4
$119K Buy
1,525
+1,197
+365% +$91.5K 0.31% 59
2020
Q3
$26K Buy
+328
New +$25.7K 0.07% 104

Other funds holding MRK

Newfound Research's MRK Position: Q1 2022 in Review

Newfound Research sold out of Merck (MRK) in Q1 2022, closing a stake of 1,173 shares — an estimated $90K sold.

Newfound Research first reported a position in MRK in Q3 2020 and held it in 6 quarters. The position peaked at $119K in Q4 2020. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Newfound Research reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Newfound Research sold 1,173 Merck shares in Q1 2022, an estimated $90K.
  • Newfound Research first reported a position in Merck in Q3 2020 and held it in 6 quarters.
  • Newfound Research's Merck position peaked at $119K in Q4 2020.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Newfound Research's 13F filing for Q1 2022, filed 4 May 2022.